Vergnes L - Search Results

1

Effect of ethyl esterification of phenolic acids on low-density lipoprotein oxidation.

Chalas J, Claise C, Edeas M, Messaoudi C, Vergnes L, Abella A, Lindenbaum A. Chalas J, et al. Among authors: vergnes l. Biomed Pharmacother. 2001 Feb;55(1):54-60. doi: 10.1016/s0753-3322(00)00011-1. Biomed Pharmacother. 2001. PMID: 11237285

2

Protective effects of the lipophilic redox conjugate tocopheryl succinyl-ethyl ferulate on HIV replication.

Edeas MA, Claise C, Vergnes L, Khalfoun Y, Barthelemy S, Labidalle S, Lindenbaum A. Edeas MA, et al. Among authors: vergnes l. FEBS Lett. 1997 Nov 24;418(1-2):15-8. doi: 10.1016/s0014-5793(97)01335-5. FEBS Lett. 1997. PMID: 9414085 Free article.

3

[Effect of the liposolubility of free radical scavengers on the production of antigen P24 from a HIV infected monocytic cell line].

Edeas M, Khalfoun Y, Lazizi Y, Vergnes L, Labidalle S, Postaire E, Lindenbaum A. Edeas M, et al. Among authors: vergnes l. C R Seances Soc Biol Fil. 1995;189(3):367-73. C R Seances Soc Biol Fil. 1995. PMID: 8521085 French.

4

Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat.

Barthelemy S, Vergnes L, Moynier M, Guyot D, Labidalle S, Bahraoui E. Barthelemy S, et al. Among authors: vergnes l. Res Virol. 1998 Jan-Feb;149(1):43-52. doi: 10.1016/s0923-2516(97)86899-9. Res Virol. 1998. PMID: 9561563

5

Biologic evaluation of curcumin and structural derivatives in cancer chemoprevention model systems.

Gafner S, Lee SK, Cuendet M, Barthélémy S, Vergnes L, Labidalle S, Mehta RG, Boone CW, Pezzuto JM. Gafner S, et al. Among authors: vergnes l. Phytochemistry. 2004 Nov;65(21):2849-59. doi: 10.1016/j.phytochem.2004.08.008. Phytochemistry. 2004. PMID: 15501252

6

Human apoA-I/C-III/A-IV gene cluster transgenic rabbits: effects of a high-cholesterol diet.

Recalde D, Baroukh N, Viglietta C, Prince S, Verona J, Vergnes L, Pidoux J, Nazeem Nanjee M, Brites F, Ochoa A, Castro G, Zakin MM, Miller NE, Marie Houdebine L. Recalde D, et al. Among authors: vergnes l. FEBS Lett. 2004 Aug 13;572(1-3):294-8. doi: 10.1016/j.febslet.2004.07.041. FEBS Lett. 2004. PMID: 15304365 Free article.

7

Human apolipoprotein A-IV reduces gastric acid secretion and diminishes ulcer formation in transgenic mice.

Vergnes L, Baroukh N, Léhy T, Moizo L, Bado A, Baralle M, Baralle FE, Zakin MM, Ochoa A. Vergnes L, et al. FEBS Lett. 1999 Oct 22;460(1):178-81. doi: 10.1016/s0014-5793(99)01332-0. FEBS Lett. 1999. PMID: 10571083 Free article.

8

Expression and secretion of human apolipoprotein A-I in the heart.

Baroukh N, Lopez CE, Saleh MC, Recalde D, Vergnes L, Ostos MA, Fiette L, Fruchart JC, Castro G, Zakin MM, Ochoa A. Baroukh N, et al. Among authors: vergnes l. FEBS Lett. 2004 Jan 16;557(1-3):39-44. doi: 10.1016/s0014-5793(03)01429-7. FEBS Lett. 2004. PMID: 14741338 Free article.

9

Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice reduces atherogenesis in response to a high fat-high cholesterol diet.

Baroukh N, Ostos MA, Vergnes L, Recalde D, Staels B, Fruchart J, Ochoa A, Castro G, Zakin MM. Baroukh N, et al. Among authors: vergnes l. FEBS Lett. 2001 Jul 27;502(1-2):16-20. doi: 10.1016/s0014-5793(01)02621-7. FEBS Lett. 2001. PMID: 11478940 Free article.

10

Regulation of the human apolipoprotein AIV gene expression in transgenic mice.

Baralle M, Vergnes L, Muro AF, Zakin MM, Baralle FE, Ochoa A. Baralle M, et al. Among authors: vergnes l. FEBS Lett. 1999 Feb 19;445(1):45-52. doi: 10.1016/s0014-5793(99)00096-4. FEBS Lett. 1999. PMID: 10069372 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters